Wip1 knockout inhibits neurogenesis by affecting the Wnt/β-catenin signaling pathway in focal cerebral ischemia in mice

Exp Neurol. 2018 Nov:309:44-53. doi: 10.1016/j.expneurol.2018.07.011. Epub 2018 Jul 23.

Abstract

Neurogenesis correlates closely with the recovery of neural function after brain ischemia but the critical proteins and signaling pathways involved remain unclear. The phosphatase WIP1 has been shown to regulate neurogenesis in models of aging. However, it is not known if WIP1 affects neurogenesis and functional recovery after brain ischemia. To explore these questions, we performed permanent middle cerebral artery occlusion (MCAO) in mice and performed BrdU labeling, neurobehavioral testing, western blotting, and immunofluorescence staining. We found that ischemia induced WIP1 expression in the area bordering the injury. Compared to wild-type mice, the knockout of the Wip1 gene inhibited neurological functional recovery, reduced the expression of doublecortin, and inactivated the Wnt/β-Catenin signaling pathway in cerebral ischemia in mice. Pharmacological activation of the Wnt/β-Catenin signaling pathway compensated for the Wip1 knockout-induced deficit in neuroblast formation in animals with MCAO. These findings indicate that WIP1 is essential for neurogenesis after brain injury by activating the Wnt/β-Catenin signaling pathway.

Keywords: Ischemic stroke; Permanent MCAO; Wip1; Wnt/β-catenin signaling pathway.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Brain Infarction / etiology
  • Bromodeoxyuridine / metabolism
  • Disease Models, Animal
  • Doublecortin Domain Proteins
  • Enzyme Inhibitors / pharmacology
  • Enzyme Inhibitors / therapeutic use
  • Gene Expression Regulation / genetics
  • In Situ Nick-End Labeling
  • Indoles / pharmacology
  • Indoles / therapeutic use
  • Infarction, Middle Cerebral Artery / drug therapy
  • Infarction, Middle Cerebral Artery / metabolism*
  • Infarction, Middle Cerebral Artery / pathology*
  • Male
  • Maleimides / pharmacology
  • Maleimides / therapeutic use
  • Mice
  • Mice, Inbred C57BL
  • Mice, Transgenic
  • Microtubule-Associated Proteins / metabolism
  • Neurogenesis / drug effects
  • Neurogenesis / genetics*
  • Neuropeptides / metabolism
  • Protein Phosphatase 2C / deficiency*
  • Protein Phosphatase 2C / genetics
  • Severity of Illness Index
  • Statistics, Nonparametric
  • Wnt Signaling Pathway / drug effects
  • Wnt Signaling Pathway / genetics*
  • beta Catenin / metabolism*

Substances

  • Doublecortin Domain Proteins
  • Enzyme Inhibitors
  • Indoles
  • Maleimides
  • Microtubule-Associated Proteins
  • Neuropeptides
  • SB 216763
  • beta Catenin
  • Ppm1d protein, mouse
  • Protein Phosphatase 2C
  • Bromodeoxyuridine